CTRI/2019/04/018513已完成未知
An open-label, balanced, randomized, single-dose, three-treatment, three-period, three-sequence, three-way crossover, oral relative bioavailability study of 2000mg of Curcuminoids from Liquid Curcumin of Halcyon Bioscience Pty Ltd, Sydney, Australia with 2000mg of Curcuminoids from reference product 1 (R1) - Curcuminoid Powder with Turmeric essential oil in vegetarian capsules and 2000mg of Curcuminoids from reference product 2 (R2) - Curcuminoid powder with Piperine in vegetarian capsules in normal, healthy, adult, human male subjects under fasting condition. - NA
Halycon Bioscience pty Ltd0 个研究点目标入组 9 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Ba/be
入排标准
入选标准
- •Healthy adult human volunteers of age between 18-45 years
排除标准
- 未提供
研究者
相似试验
已完成
1 期
A clinical trial study to determine the bioavailability of different formulations of curcumin tablets.CTRI/2021/06/034356KMS Health Center Pvt Ltd
尚未招募
Unknown
Bioequivalence study of Propiomazine Tablets 25 mg in healthy, adult, human Subjects under fasting conditions.CTRI/2024/04/066196Centaur Pharmaceuticals Pvt. Ltd
已完成
1 期
A clinical trial study to determine the oral bio-availability of Caffxtend capsules.CTRI/2021/06/034185Inventia Healthcare Limited16
尚未招募
不适用
Clopidogrel Tablets USP 300 mgBE Fasting StudyCTRI/2019/04/018856Polygen Pharmaceuticals Inc
已完成
1 期
Comparative assessment of the absorption of a generic formulation of asenapine sublingual tablet against the innovator asenapine sublingual tablet conducted under fasting conditions in healthy male and female volunteersBioequivalence study on asenapine formulations.Schizophrenia in adultsOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveMental Health - SchizophreniaACTRN12613000650796Zenith Technology Corporation Limited36
